MEI Pharma (MEIP) Competitors $2.75 +0.03 (+1.10%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MEIP vs. ZIVO, RVPH, ELYM, BYSI, VHAQ, PDSB, OPTN, GANX, IVVD, and IMMXShould you be buying MEI Pharma stock or one of its competitors? The main competitors of MEI Pharma include ZIVO Bioscience (ZIVO), Reviva Pharmaceuticals (RVPH), Eliem Therapeutics (ELYM), BeyondSpring (BYSI), Viveon Health Acquisition (VHAQ), PDS Biotechnology (PDSB), OptiNose (OPTN), Gain Therapeutics (GANX), Invivyd (IVVD), and Immix Biopharma (IMMX). These companies are all part of the "pharmaceutical products" industry. MEI Pharma vs. ZIVO Bioscience Reviva Pharmaceuticals Eliem Therapeutics BeyondSpring Viveon Health Acquisition PDS Biotechnology OptiNose Gain Therapeutics Invivyd Immix Biopharma ZIVO Bioscience (NASDAQ:ZIVO) and MEI Pharma (NASDAQ:MEIP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking, profitability, risk and earnings. Which has better earnings and valuation, ZIVO or MEIP? MEI Pharma has higher revenue and earnings than ZIVO Bioscience. ZIVO Bioscience is trading at a lower price-to-earnings ratio than MEI Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZIVO Bioscience$15.85K4,135.02-$7.78M-$4.88-3.71MEI Pharma$65.30M0.28$17.78M-$6.99-0.39 Does the media refer more to ZIVO or MEIP? In the previous week, MEI Pharma had 3 more articles in the media than ZIVO Bioscience. MarketBeat recorded 3 mentions for MEI Pharma and 0 mentions for ZIVO Bioscience. MEI Pharma's average media sentiment score of 1.19 beat ZIVO Bioscience's score of 0.00 indicating that MEI Pharma is being referred to more favorably in the news media. Company Overall Sentiment ZIVO Bioscience Neutral MEI Pharma Positive Do insiders and institutionals believe in ZIVO or MEIP? 12.8% of ZIVO Bioscience shares are owned by institutional investors. Comparatively, 52.4% of MEI Pharma shares are owned by institutional investors. 21.5% of ZIVO Bioscience shares are owned by insiders. Comparatively, 3.1% of MEI Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts rate ZIVO or MEIP? MEI Pharma has a consensus price target of $7.00, suggesting a potential upside of 154.55%. Given MEI Pharma's higher probable upside, analysts clearly believe MEI Pharma is more favorable than ZIVO Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZIVO Bioscience 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00MEI Pharma 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community believe in ZIVO or MEIP? MEI Pharma received 307 more outperform votes than ZIVO Bioscience when rated by MarketBeat users. Likewise, 62.37% of users gave MEI Pharma an outperform vote while only 60.74% of users gave ZIVO Bioscience an outperform vote. CompanyUnderperformOutperformZIVO BioscienceOutperform Votes9960.74% Underperform Votes6439.26% MEI PharmaOutperform Votes40662.37% Underperform Votes24537.63% Which has more volatility & risk, ZIVO or MEIP? ZIVO Bioscience has a beta of 0.14, indicating that its stock price is 86% less volatile than the S&P 500. Comparatively, MEI Pharma has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Is ZIVO or MEIP more profitable? MEI Pharma has a net margin of 0.00% compared to ZIVO Bioscience's net margin of -11,068.75%. ZIVO Bioscience's return on equity of 0.00% beat MEI Pharma's return on equity.Company Net Margins Return on Equity Return on Assets ZIVO Bioscience-11,068.75% N/A -2,240.92% MEI Pharma N/A -84.80%-65.24% SummaryMEI Pharma beats ZIVO Bioscience on 12 of the 16 factors compared between the two stocks. Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEIP vs. The Competition Export to ExcelMetricMEI PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.32M$6.54B$5.25B$8.80BDividend YieldN/A2.91%5.07%4.00%P/E Ratio-0.3910.2586.1216.98Price / Sales0.28176.191,077.10114.31Price / Cash0.4557.6743.2137.77Price / Book0.554.885.044.89Net Income$17.78M$154.38M$122.32M$228.40M7 Day Performance5.77%-8.12%-4.65%-3.68%1 Month Performance1.85%-3.16%-0.99%0.03%1 Year Performance-52.59%-4.63%23.64%13.82% MEI Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEIPMEI Pharma4.4235 of 5 stars$2.75+1.1%$7.00+154.5%-53.1%$18.32M$65.30M-0.39100Short Interest ↓Positive NewsZIVOZIVO BioscienceN/A$19.27-12.2%N/A+370.1%$68.32M$15,850.00-3.9510Gap DownRVPHReviva Pharmaceuticals3.7567 of 5 stars$2.01+5.8%$15.50+671.1%-54.2%$67.22MN/A-1.815Short Interest ↓Gap UpELYMEliem TherapeuticsN/A$2.25+8.7%N/A-26.5%$66.94MN/A-4.2520News CoverageBYSIBeyondSpringN/A$1.71+4.9%N/A+86.4%$66.74M$1.88M0.0080Positive NewsGap UpVHAQViveon Health AcquisitionN/A$10.00flatN/AN/A$66.49MN/A0.002PDSBPDS Biotechnology1.7573 of 5 stars$1.77-1.9%$11.67+561.0%-67.1%$66.03MN/A-1.5220OPTNOptiNose4.5279 of 5 stars$6.53+0.5%$26.00+298.2%-73.6%$65.69M$75.67M-23.32190Short Interest ↓Positive NewsGANXGain Therapeutics2.811 of 5 stars$2.46+1.2%$7.25+194.7%-37.2%$65.25M$50,000.00-2.2420Positive NewsGap UpIVVDInvivyd3.2716 of 5 stars$0.55-2.2%$7.89+1,347.2%-90.6%$65.19M$11.56M-0.28100Short Interest ↑Gap DownIMMXImmix Biopharma3.2565 of 5 stars$2.35flat$7.00+197.9%-63.5%$64.64MN/A-2.769Short Interest ↓ Related Companies and Tools Related Companies ZIVO Bioscience Alternatives Reviva Pharmaceuticals Alternatives Eliem Therapeutics Alternatives BeyondSpring Alternatives Viveon Health Acquisition Alternatives PDS Biotechnology Alternatives OptiNose Alternatives Gain Therapeutics Alternatives Invivyd Alternatives Immix Biopharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MEIP) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MEI Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEIP Stock Alerts